Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5030 total record number 58 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 468 out of 503
5030 citations found

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • 2.2.2. Cell Culture

    HEK293 human embryonic kidney cells (gift of Frank Graham) were maintained
    in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum
    (FBS). This cell line has been transformed with the E1 region of type 5
    adenovirus (Graham et al., 1977). NIH3T3 murine embryonic fibroblasts (ATCC
    #CRL-1658) were maintained in high glucose Dulbecco’s Modified Eagle Medium
    (DMEM) supplemented with 10% FBS. hTERT-HME1 human mammary
    epithelial cells (ATCC #CRL-4010) were maintained in DMEM/F12 supplemented
    with 10 mM HEPES, 10 µg/mL insulin, 5 mg/mL BSA, 10 ng/mL Cholera toxin, 10
    ng/mL epidermal growth factor (EGF), and 0.5 µg/mL hydrocortisone. MCF-10A
    human mammary epithelial cells (ATCC #CRL10317) were maintained in
    modified DMEM/F12 with 5% FBS, 10 µg/mL insulin, 10 ng/mL Cholera toxin, 20
    ng/mL EGF, and 0.5 µg/mL hydrocortisone. MTHJ murine mammary
    adenocarcinoma cells were established as described (Hummel, Safroneeva, and
    Mossman, 2005) and maintained in high glucose Dulbecco’s Modified Eagle
    Medium (DMEM) supplemented with 10% FBS. ZR-75-1 human breast cancer
    cells (ATCC #CRL-1500) were cultured in RPMI 1640 supplemented with 10%
    FBS. All cell lines were supplemented with 2 mM L-glutamine, 0.1 mg/mL
    penicillin, and 100 U/mL streptomycin, and grown at 37ºC in a humidified
    atmosphere at 5% CO2. All media were purchased from Sigma Chemicals and
    all supplements were purchased from Gibco except for cholera toxin (List
    Biologicals)
    .

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration

Starossom, SC;Mascanfroni, ID;Imitola, J;Cao, L;Raddassi, K;Hernandez, SF;Bassil, R;Croci, DO;Cerliani, JP;Delacour, D;Wang, Y;Elyaman, W;Khoury, SJ;Rabinovich, GA;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: SNAPtide® Peptide Substrate (o-Abz/Dnp) for C. botulinum Type A Neurotoxin

  • SNAPtide assay of BoNT/A LC with screened compounds:

    SNAPtide (o-Abz-Dnp) was purchased from List Biological Laboratories and was used
    for analyzing the kinetics of protease inhibition.  The BoNT/A LC is included in a mixture
    (denoted Big Mix) to minimize discrepancies in concentration of enzyme and to have a constant
    concentration of BoNT/A LC throughout the whole experiment.  Big Mix includes 1xPBS,
    20M Zn2+, and 0.2M LC/A-SUMO.   Compounds B, D, and E were dissolved in DMSO and
    the LC Buffer (1xPBS, 20M Zn2+) and DMSO was tested as a negative control to determine any
    possible interference in fluorescence.  The catalytic activity of BoNT/A LC is largely insensitive
    to the presence of DMSO, making this an ideal co-solvent (Boldt et al, 2006).   The SNAPtide
    assay was initiated by the addition of 2M SNAPtide and the reaction was allowed to proceed to
    5% completion and the initial rate was determined.  The protease activity was monitored by the
    increase of donor fluorescence intensity.  The compound 7-(phenyl(8-quinolinylamino)-8
    quinolinol, better known as QAQ (84096), has previously shown in an HPLC-based enzymatic
    assay to inhibit BoNT/A LC by 74% at 20M enzyme concentration (Lai et al, 2009). …

Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation

Mei, F;Guo, S;He, Y;Wang, L;Wang, H;Niu, J;Kong, J;Li, X;Wu, Y;Xiao, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • EAE Mice Model and Treatment Protocols:

    C57BL/6 mice were obtained from the Animal Center of Third Military Medical University. All experiments were performed in accordance with Health Guide for the Care and Use of Laboratory Animals, with the approval of Third Military Medical University Committee on Animal Care (permission NO: SCXK-JUN-2007-015). Female C57BL/6 mice (N=43, 8 weeks old) were immunized subcutaneously with 200 µg of MOG3555 peptide (Invitrogen, Carlsbad, CA) emulsified in complete Freund adjuvant (CFA, Sigma Aldrich, Saint Louris, MO) on Day 0 and Day 7, and received 300 ng pertussis toxin (PT, List Biological Laboratories, Campbell, CA) in 0.1 ml PBS intraperitoneal at the time of immunization and 48 hours later. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase

Lijek, RS;Luque, SL;Liu, Q;Parker, D;Bae, T;Weiser, JN;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Immunization with Purified Antigens:

    As previously described (38), mice were immunized intranasally with 4 µg of recombinant protein and 1 µg cholera toxin as adjuvant (List Biological Laboratories) per 20 µL dose. Control mice received adjuvant alone. Three immunizations were given at weekly intervals, followed by intranasal S. aureus challenge at week 5, as described above.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Strategies to alleviate original antigenic sin responses to influenza viruses

Kim, JH;Davis, WG;Sambhara, S;Jacob, J;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Animal models and ethics statement:

    … All immunizations were performed by instilling 20 µl of a mixture of PBS, 1 µg of cholera toxin (CT; List Biologicals, Campbell, CA) and either 4 µg of the indicated purified pneumococcal protein or 100 µg of WCC as immunogens onto the nares of gently restrained unanesthetized mice. Control animals were immunized with CT mixed in PBS alone to control for any nonspecific effect of the adjuvant alone. Animals were immunized intranasally twice at one-week intervals. …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl-induced fibrogenesis in mice

Mattos, A;de Jager-Krikken, A;de Haan, M;Beljaars, L;Poelstra, K;

Product: Unspecified List Labs LPS

  • … After this, cells were preincubated for 30 min with 50 ng/mL of IL-10, 5PEGIL-10 or 20PEGIL-10 in 0.1 mL FBS-free medium containing 0.5% normal mouse serum. At t = 0, 25 ng/mL of LPS (E. coli, List Biological Laboratories, INC., USA) was added to the wells. …

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation

Lin, T;Sammy, F;Yang, H;Thundivalappil, S;Hellman, J;Tracey, KJ;Warren, HS;

Product: LPS from Escherichia coli O55:B5

  • Materials:

    The following TLR agonists were purchased: smooth LPS from E. coli O55:B5 (List Biologicals)

    Macrophage culture and cytokine assays:

    BMDMs were washed three times in serum-free medium, followed by incubation overnight with HMGB1, with or without hemoglobin, or with different TLR agonists as desired at indicated concentrations.NOTE:  At the time this paper was written, Product #203 (5mg – LPS from Escherichia coli O55:B5) was utilized.

    NOTE:  At the time this paper was written, Product #203 (5mg – LPS from Escherichia coli O55:B5) was utilized.

    Product #203 (5 mg – LPS from Escherichia coli O55:B5) is no longer sold.

    Product #203A (2.5 mg – LPS from Escherichia coli O55:B5) is available for purchase.